| Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia (NCT07397325) | Applied Biology, Inc. | 2026-05-16 |
| HERO-UTUC: Intravesical RC48 After RNU for HER2+ UTUC (NCT07591805) | RenJi Hospital | 2026-05-16 |
| Snacks and Brain Health (NCT07348406) | Texas Tech University Health Sciences Center | 2026-05-15 |
| Osimertinib Plus Capivasertib in NSCLC With PIK3CA/AKT1/PTEN Alterations Following Prior 1L Osimertinib (NCT07486648) | Shanxi Province Cancer Hospital | 2026-05-15 |
| Mitigating Toxic Impact: The Role of Coenzyme Q10 in Post-Exposure Protection (NCT06962657) | University of California, San Diego | 2026-05-15 |
| Subjective Experience Following Psilocybin (NCT06768944) | University of Calgary | 2026-05-15 |
| Treatment of Truncated ALK-positive Bone Cancer Using Crizotinib (Xalkori) or Alectinib (Alecensa) (NCT07560410) | China Medical University Hospital | 2026-05-15 |
| A Study of Chidamide Combined With Ivonescimab in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) With Acquired Resistance to Immunotherapy and High Yes-associated Protein (YAP) Expression (NCT07412262) | Guangdong Association of Clinical Trials | 2026-05-15 |
| A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric Disease (NCT07093333) | Arialys Australia Pty Ltd | 2026-05-15 |
| Ultrasound Guided Erectror Spinae Block Versus Intracavitary During Medical Thoracoscopy (NCT07572019) | Kafrelsheikh University | 2026-05-15 |
| Phase 2b, Open Label, Multisite, Randomized Crossover Study of DPP Versus 2PR (NCT07288190) | HIV Prevention Trials Network | 2026-05-15 |
| Post-Operative Use of FS2 to Mitigate Scarring in Burn Patients (NCT06807021) | Birch BioMed Inc | 2026-05-15 |
| Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease. (NCT07512362) | Bernard (Barry) Baumel | 2026-05-15 |
| Efficacy and Safety of Induction Benmelstobart Plus Anlotinib and Chemotherapy Followed by Concurrent Chemoradiotherapy and Benmelstobart Maintenance Versus Concurrent Chemoradiotherapy Followed by Benmelstobart Maintenance in Patients With Unresectable Stage III NSCLC (NCT07643350) | The Third Xiangya Hospital of Central South University | 2026-05-15 |
| A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight (NCT07589608) | Eli Lilly and Company | 2026-05-15 |
| 2-HOBA in Systemic Lupus Erythematosus (NCT07225543) | Vanderbilt University Medical Center | 2026-05-15 |
| Clinical Study of CVL006 Combination With 9MW2821 (NCT07615660) | Convalife (Shanghai) Co., Ltd. | 2026-05-15 |
| DMSO Dual-Route Therapy for Refractory Tinnitus in Long-COVID and Post-COVID-19 Vaccine Injury (NCT07567274) | Leading Edge Clinic | 2026-05-15 |
| Probiotics for Abemaciclib-Induced Abdominal Discomfort. (NCT07605728) | Leeuwenhoek Laboratories Co. Ltd. | 2026-05-15 |
| A Phase I/II Clinical Study to Evaluate SKG0201 Injection in Subjects With Spinal Muscular Atrophy Type I (NCT07554924) | Lanyue Biotech (Hangzhou) Co., Ltd. | 2026-05-15 |
| Selinexor Combined With Reduced-Dose Radiotherapy For Early-Stage Extranodal NK/T-Cell Lymphoma (NCT07554482) | Beijing Tongren Hospital | 2026-05-15 |
| A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease (NCT07599670) | AbbVie | 2026-05-15 |
| Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation (NCT07549503) | National Institute of Allergy and Infectious Diseases (NIAID) | 2026-05-14 |
| A Clinical Trial to Assess the Safety and PK of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii Complex (NCT06087536) | Omnix Medical Ltd | 2026-05-14 |
| Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus (NCT07142252) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2026-05-14 |
| Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer (NCT07392892) | Pfizer | 2026-05-14 |
| LME-Guided Precision Combination Therapy in B-cell Lymphoma Patients After CD19 CAR-T Failure (NCT07602322) | Ruijin Hospital | 2026-05-14 |
| Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer (NCT07339059) | Bindu R Potugari | 2026-05-14 |
| A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression (NCT07610473) | Draig Therapeutics Ltd | 2026-05-14 |
| Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis (NCT07572383) | Peter Caravan | 2026-05-14 |
| Ceftriaxone for Post-Treatment Lyme Disease (NCT06785402) | Hackensack Meridian Health | 2026-05-14 |
| A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated (NCT07553429) | Boehringer Ingelheim | 2026-05-14 |
| A Prospective, Single-arm, Phase II Clinical Trial of Becotatug Vedotin for Injection Combined With Pucotenlimab Injection as a First-line Treatment for Platinum-intolerant Advanced Head and Neck Squamous Cell Carcinoma (NCT07628855) | Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center | 2026-05-14 |
| Fostrox Plus Lenvatinib vs Lenvatinib in Advanced Hepatocellular Carcinoma After First-line Immunotherapy (NCT07493668) | CHA University | 2026-05-14 |
| Clinical Trial of Recombinant RSV Vaccine (CHO Cell) (Adjuvanted) in Chinese Population Aged 18 Years and Older. (NCT07582796) | Ab&B Bio-tech Co., Ltd.JS | 2026-05-14 |
| Clinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic Hepatitis B Virus Infection (NCT07519330) | Huahui Health | 2026-05-14 |
| PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC (NCT07630363) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-05-14 |
| Subanesthetic Ketamine Infusions for Depressive Symptoms in Intensive Care Unit Patients (NCT07639359) | Hospital Italiano de Buenos Aires | 2026-05-14 |
| A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of VGN-R08b in Patients With Type III Gaucher's Disease (NCT07603050) | Shanghai Vitalgen BioPharma Co., Ltd. | 2026-05-14 |
| A Proof-of-Concept Study of LAD328 in Adults With Hidradenitis Suppurativa (NCT07547813) | Almirall, S.A. | 2026-05-13 |
| Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic Retinopathy (NCT07501052) | Sam Chun Dang Pharm. Co. Ltd. | 2026-05-13 |
| Optimizing Hydroxyurea Therapy in Children With Sickle Cell Anemia In Malaria Endemic Areas: The NOHARM Maximum Tolerated Dose (MTD) Study (NCT07708714) | Children's Hospital Medical Center, Cincinnati | 2026-05-13 |
| Pain Control for Cervical Ripening Balloon (NCT07268118) | Beth Israel Deaconess Medical Center | 2026-05-13 |
| A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer (NCT07287098) | Eli Lilly and Company | 2026-05-13 |
| A Study of VRT106, Combined With Camrelizumab, and Apatinib for Advanced HCC (NCT07589244) | Guangzhou Virotech Pharmaceutical Co., Ltd. | 2026-05-13 |
| First Clinical Study to Evaluate Safety, Tolerability & PK of DX243 in Healthy Volunteers and Patients With Hearing Loss (NCT07637981) | Dendrogenix | 2026-05-13 |
| Serplulimab Monotherapy in Elderly Patients With NSCLC and PD-L1 TPS ≥ 50% (NCT07596121) | Tang-Du Hospital | 2026-05-13 |
| A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis (NCT07501702) | Vertex Pharmaceuticals Incorporated | 2026-05-13 |
| Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma (NCT07497607) | Sara Medek | 2026-05-13 |
| Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas (NCT06465199) | Milton S. Hershey Medical Center | 2026-05-13 |
| Elacestrant in Advanced Triple Positive Breast Cancer (NCT07612215) | NYU Langone Health | 2026-05-13 |
| Phase 2 Study of Apremilast in Women and Men With Alcohol Use Disorder (NCT07029529) | Yale University | 2026-05-12 |
| Endoscopic Ultrasound-Guided Chemoablation for the Treatment of Pancreatic Cystic Neoplasms (NCT07529483) | Ohio State University Comprehensive Cancer Center | 2026-05-12 |
| Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors (NCT07424092) | Clinica Universidad de Navarra, Universidad de Navarra | 2026-05-12 |
| A Study to Assess the Safety, Tolerability and Efficacy of ION775 (NCT07604974) | Ionis Pharmaceuticals, Inc. | 2026-05-12 |
| A Phase Ⅱ/Ⅲ Clinical Trial of RC148 Plus Chemotherapy as 1L Therapy for Unresectable or Metastatic Colorectal Cancer (NCT07462143) | RemeGen Co., Ltd. | 2026-05-12 |
| Safety of RotigotiNe in Patients With Autosomal Dominant Polycystic Kidney Disease (NCT06291116) | University Hospital, Rouen | 2026-05-12 |
| An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease (NCT07503886) | Dompé Farmaceutici S.p.A | 2026-05-12 |
| Nintedanib With or Without Dextromethorphan in Patients With Idiopathic Pulmonary Fibrosis (IPF) (NCT07583589) | First Affiliated Hospital of Wenzhou Medical University | 2026-05-12 |
| A Study of Ivonescimab in People With Non-Small Cell Lung Cancer (NCT07594522) | Memorial Sloan Kettering Cancer Center | 2026-05-12 |
| Study to Evaluate the Effect of HT-4253 for the Prevention of Alzheimer's Disease in APOE4 Carriers (NCT07399171) | Halia Therapeutics, Inc. | 2026-05-12 |
| Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS) (NCT07304817) | University Medical Center Groningen | 2026-05-12 |
| MTOR Inhibitors in Older Adults (NCT06727305) | University of Texas Southwestern Medical Center | 2026-05-11 |
| SELECTmeso A Trial for Patients With Relapsed Malignant Mesothelioma SELECTmeso1 A Trial of BMS-986504 in Patients With MTAP-deficient Relapsed Mesothelioma (NCT07602946) | University of Southampton | 2026-05-11 |
| A Study of TAK-505 in Adults With Solid Tumors (NCT07436728) | Takeda | 2026-05-11 |
| A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Subjects With Bipolar I Disorder (NCT07540338) | Alzamend Neuro, Inc. | 2026-05-11 |
| Emapalumab Prophylaxis of Bispecific T-Cell Engagers (BiTEs) Associated CRS and ICANS (NCT07567014) | NYU Langone Health | 2026-05-11 |
| Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) Cancers (NCT07539311) | Genmab | 2026-05-11 |
| Efficacy and Safety of NB003 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) (NCT07379047) | Ningbo Newbay Technology Development Co., Ltd | 2026-05-11 |
| A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1) (NCT07575932) | Pfizer | 2026-05-11 |
| Behavioral Economic Attributes of Recreation (NCT07282418) | Rush University Medical Center | 2026-05-11 |
| Evaluate the Safety and Efficacy of HL-1186 Tablet for Postoperative Analgesia in Abdominal Surgery (NCT07709598) | Shanghai Huilun Pharmaceutical Co., Ltd. | 2026-05-11 |
| Comparing of Sesame Oil, Nitroglycerin Ointment, and Aloe Vera Gel (NCT07346677) | University of Basrah | 2026-05-11 |
| Elacestrant and Exemestane for Patients With Pretreated HR+/HER2- Metastatic Breast Cancer and [18F] FES-avid Lesions (COMBINE) (NCT07395336) | European Institute of Oncology | 2026-05-11 |
| Neoadjuvant Sacituzumab Govitecan Plus Tagitanlimab for Resectable Head and Neck Squamous Cell Carcinoma (NCT07492914) | West China Hospital | 2026-05-11 |
| Efficacy and Safety of Sacituzumab Tirumotecan (SKB264) in Combination With Toripalimab in Patients With Initially Unresectable Stage III NSCLC (NCT06706219) | Hunan Province Tumor Hospital | 2026-05-10 |
| Relatrilfa-α Plus Single-Agent Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-III NSCLC (Phase 2) (NCT07550920) | Tianjin Medical University Cancer Institute and Hospital | 2026-05-10 |
| Iparomlimab and Tuvonralimab Injection (QL1706) Combined With DOS as Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Stomach and Gastroesophageal Junction (NCT07776639) | Yongxu Jia | 2026-05-10 |
| A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Therapy for Early Relapse Colorectal Cancer After Adjuvant Chemotherapy (NCT07604909) | Fudan University | 2026-05-10 |
| Eque-cel for the Treatment of Patients With Relapsed/Refractory Multiple Myeloma (NCT07510100) | Nanjing IASO Biotechnology Co., Ltd. | 2026-05-10 |
| TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis (NCT06726577) | Talengen Institute of Life Sciences, Shenzhen, P.R. China. | 2026-05-10 |
| Intravesical Aminophylline to Facilitate Ureteroscopic Access in Children With Distal Ureteral Stones. (NCT07617896) | Beni-Suef University | 2026-05-09 |
| SCTB41 Combined With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer (NCT07662395) | Sinocelltech Ltd. | 2026-05-09 |
| Evaluate the Safety and Efficacy of HL-1186 Tablet for Postoperative Analgesia in Orthopedic Surgery (NCT07699601) | Shanghai Huilun Pharmaceutical Co., Ltd. | 2026-05-09 |
| CBP-0276 to Reduce Opioid Use in Adults Undergoing Major Orthopedic Surgery (NCT07687966) | Clarent Biopharma, Inc. | 2026-05-08 |
| A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants (NCT07535034) | Crystalys Therapeutics | 2026-05-08 |
| Melatonin Versus Placebo for Bipolar Disorder (NCT07472075) | Lars Vedel Kessing | 2026-05-08 |
| Long Term Evaluation of Scapular-inserted Contraceptive Implants (NCT07201402) | Yale University | 2026-05-08 |
| Adapt NK for High Risk Myeloid Diseases as Bridge to Allo HSCT (NCT07591649) | Masonic Cancer Center, University of Minnesota | 2026-05-08 |
| Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia (NCT06738368) | University of Washington | 2026-05-08 |
| Phase 2 Cachexia Clinical Trial to Evaluate the Efficacy and Safety of ASCA101 (NCT07168226) | MetaFines | 2026-05-08 |
| Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB (NCT06568484) | Johns Hopkins University | 2026-05-08 |
| A Study of PLH-2301 in Subjects With Sarcopenia (NCT07390552) | Pluto Inc. | 2026-05-08 |
| Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis (NCT07610837) | AstraZeneca | 2026-05-07 |
| A Study of VRT106 in Combination With Radiotherapy in Adult Patients With Diffuse Midline Glioma / Diffuse Intrinsic Pontine Glioma (NCT07589257) | Guangzhou Virotech Pharmaceutical Co., Ltd. | 2026-05-07 |
| VABu Conditioning in Elderly AML HSCT (NCT07583888) | The First Affiliated Hospital of Soochow University | 2026-05-07 |
| Allogeneic Adipose Tissue Derived-stem Cells in Alzheimer Disease (NCT07367815) | University Hospital, Toulouse | 2026-05-07 |
| An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients. (NCT07543120) | Novartis Pharmaceuticals | 2026-05-07 |
| An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease (NCT07438405) | Amgen | 2026-05-07 |
| Efficacy of L-menthol on Breathlessness in Asthma (NCT07500974) | Region Skane | 2026-05-07 |